Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil☆

Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2019.12.008
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Managing Refractory Glaucoma With a Fixed Combination of Bimatoprost (0.03%) and Timolol (0.5%)

Clinical Ophthalmology
Ophthalmology
2008English

A Comparative Study on Safety and Efficacy of Travoprost and Brimonidine/Timolol Fixed Combination in Patients of Primary Open Angle Glaucoma

International Journal of Basic and Clinical Pharmacology
2015English

Preliminary Results Following the Use of a Fixed Combination of Timolol–brimonidine in Patients With Ocular Hypertension and Primary Open-Angle Glaucoma

Clinical Ophthalmology
Ophthalmology
2009English

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

American Journal of Ophthalmology
Ophthalmology
2016English

A Randomised, Double Masked, Multicentre Clinical Trial Comparing Bimatoprost and Timolol for the Treatment of Glaucoma and Ocular Hypertension

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2003English

Real-Life Experience of Using Brinzolamide/Brimonidine Fixed Drop Combination in a Tertiary Glaucoma Centre

International Ophthalmology
Ophthalmology
2019English

A Monocular Trial of Fixed Combination of Dorzolamide-Timolol for Primary Open-Angle Glaucoma

Journal of the Korean Glaucoma Society
2019English

Fixed Combination Therapies in Glaucoma

2015English

Treatment of Glaucoma With the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%

European Ophthalmic Review
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy